Back to mobile site
Get it on Google Play

Abivax reports Phase 3 maintenance trial results for obefazimod

June 29, 2026 4:06 PM EDT Send to a Friend
Abivax SA (Euronext Paris: ABVX / Nasdaq: ABVX) reported topline results from ABTECT Maintenance Part 2, a supplemental portion of ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login